Effects of Extracorporeal Shock Wave Therapy on Shoulder Internal Rotator Spasticity in Post-Stroke Patients: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Extracorporeal shock wave therapy (ESWT) has shown potential in reducing post-stroke limb spasticity. This study aims to evaluate the efficacy of focused ESWT on shoulder internal rotator spasticity in post-stroke patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged 18 years or older with unilateral cerebral stroke.

• Restricted passive external rotation of the spastic shoulder by more than 20 degrees.

• A Modified Ashworth Scale score of 1 or higher for shoulder internal rotator spasticity.

• Stable medical condition and vital signs.

• Clear consciousness, able to follow instructions.

Locations
Other Locations
Taiwan
Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital
RECRUITING
Taipei
Contact Information
Primary
Shu-mei Yang, MD
b99401109@gmail.com
0972653675
Time Frame
Start Date: 2025-07-23
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Focused Extracorporeal Shock Wave
Participants in this arm will receive focused Extracorporeal Shock Wave Therapy (ESWT) targeting four specific muscles: subscapularis, pectoralis major, latissimus dorsi, and teres major muscles. Each muscle will receive 1,000 shockwave shots per session, accumulating to a total of 4,000 shots across all targeted muscles in each session. The treatment will be administered twice a week for two consecutive weeks, resulting in a total of four treatment sessions.
Placebo_comparator: Placebo-Controlled Shockwave Therapy
Participants in this arm will receive placebo-controlled focused ESWT, mirroring the treatment protocol of the experimental group but without the application of active shockwaves.
Related Therapeutic Areas
Sponsors
Leads: National Taiwan University Hospital

This content was sourced from clinicaltrials.gov